Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03557749 · ClinicalTrials.gov registry record
Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
A clinical trial, sponsored by Masonic Cancer Center, University of Minnesota.
- Terminated
- Registry status
- 210
- Enrollment target
NCT03557749: Clinical Trial study, sponsored by Masonic Cancer Center, University of Minnesota.
NCT03557749 is a clinical trial that was terminated before completion, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 210 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03557749 was terminated before completion, sponsored by Masonic Cancer Center, University of Minnesota.
- TERMINATED
- Registry status
- 210 participants
- Enrollment target
Study Summary
This protocol serves as a mechanism to collect, store, and distribute bodily fluid and tissue samples obtained from Hematopoietic Cell Transplant (HCT) or novel immunotherapy patients and their donors at the Masonic Cancer Center in order to conduct correlative studies of the immune system, microbiota, and their interactions. Fluid (including but not limited to, blood, urine, saliva, cerebrospinal fluid, bronchoalveolar lavage fluid) sample log-in, processing, relabeling, and storage is performed by the Masonic Cancer Center (MCC) Translational Therapy Lab (TTL).
Primary Outcome
Incidence of neutrophil recovery
Interventions
- DIAGNOSTIC_TEST Stool Sample
- DIAGNOSTIC_TEST Blood Sample
- DIAGNOSTIC_TEST Urine Sample
- DIAGNOSTIC_TEST Bronchoalveolar Lavage (BAL) fluid
- DIAGNOSTIC_TEST Gastrointestinal biopsy x 2-4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2018-09-21 |
| Est. Completion | 2023-08-15 |
Why NCT03557749 stopped before completion
NCT03557749 is an observational study that tracks outcomes without assigning an intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which Stool Sample is the first listed.
NCT03557749 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03557749 about?
NCT03557749 is a clinical study titled "Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies". This protocol serves as a mechanism to collect, store, and distribute bodily fluid and tissue samples obtained from Hematopoietic Cell Transplant (HCT) or novel immunotherapy patients and their donors at the Masonic Cancer Center in order to conduct correlative studies of the immune system, microbio...
What is the current status of trial NCT03557749?
This trial is currently terminated. The enrollment target is 210 participants. The study started on 2018-09-21. Estimated completion is 2023-08-15.
What interventions are being tested in trial NCT03557749?
The interventions under investigation include: Stool Sample (DIAGNOSTIC_TEST), Blood Sample (DIAGNOSTIC_TEST), Urine Sample (DIAGNOSTIC_TEST), Bronchoalveolar Lavage (BAL) fluid (DIAGNOSTIC_TEST), Gastrointestinal biopsy x 2-4 (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03557749?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI